title: Dexamethasone increases apolipoprotein A-I concentrations in medium and apolipoprotein A-I mRNA abundance from Hep G2 cells.
abstract: Glucocorticoid hormones increase high-density lipoprotein (HDL) levels in vivo. However, there is little known about the mechanism by which glucocorticoids alter HDL metabolism. Hep G2 cells were incubated with dexamethasone to determine the effect of glucocorticoids on apolipoprotein (apo) A-I secretion. Dexamethasone increased apo A-I concentration in a dose-dependent fashion. After 24 hours, 5.5 x 10(-5) mol/L dexamethasone increased apo A-I accumulation in culture medium by 54%. Detectable increases in apo A-I concentration were noted in medium by 5 hours of incubation and persisted up to 48 hours. Cellular apo A-I mRNA concentration increased by 28% after incubation with dexamethasone for 24 hours. The increase in apo A-I mRNA concentration was detectable within 3 hours after incubation with dexamethasone. In contrast, incubation with dexamethasone decreased apo B concentration by 43% in culture medium, but it had no effect on cellular apo B mRNA concentrations. Dexamethasone had little effect on cholesterol and triglyceride accumulation in the medium. Incubation with albumin alone did not affect apo A-I concentration, but it decreased apo B concentration by 30% in the medium. Incubation with albumin and dexamethasone had no effect on apo A-I concentration in medium and had no additive effect on apo B concentration. These data suggest dexamethasone increases secretion of apo A-I by Hep G2 cells by increasing mRNA levels.
authors.affiliation: Department of Internal Medicine, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC.
authors.forename: V K
authors.initials: VK
authors.lastname: Varma
authors.forename: T K
authors.initials: TK
authors.lastname: Smith
authors.forename: M
authors.initials: M
authors.lastname: Sorci-Thomas
authors.forename: W H
authors.initials: WH
authors.lastname: Ettinger
mesh_terms: D000418:Albumins / Q000494:pharmacology; D016632:Apolipoprotein A-I / Q000032:analysis* / Q000235:genetics* / Q000378:metabolism; D006528:Carcinoma, Hepatocellular / Q000737:chemistry / Q000235:genetics / Q000473:pathology*; D002784:Cholesterol / Q000032:analysis / Q000378:metabolism; D003470:Culture Media / Q000032:analysis*; D003907:Dexamethasone / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008074:Lipoproteins / Q000378:metabolism; D008113:Liver Neoplasms / Q000737:chemistry / Q000235:genetics / Q000473:pathology*; D012333:RNA, Messenger / Q000032:analysis* / Q000235:genetics; D013997:Time Factors; D014280:Triglycerides / Q000032:analysis / Q000378:metabolism; D014407:Tumor Cells, Cultured / Q000737:chemistry
chemical_list: D000418:Albumins; D016632:Apolipoprotein A-I; D003470:Culture Media; D008074:Lipoproteins; D012333:RNA, Messenger; D014280:Triglycerides; D003907:Dexamethasone; D002784:Cholesterol